Non-Small Cell A171901
Study #A171901Older Non-Small Cell Lung Cancer Patients (>/= 70 Years of Age) Treated with First-Line MK-3475 (Pembrolizumab) +/- Chemotherapy (Oncologist’s / Patient’s Choice)
Back To Clinical Trials NCI Database Entry
Older Non-Small Cell Lung Cancer Patients (>/= 70 Years of Age) Treated with First-Line MK-3475 (Pembrolizumab) +/- Chemotherapy (Oncologist’s / Patient’s Choice)
Back To Clinical Trials NCI Database Entry